I
t is generally accepted that the incidence of both asymptomatic and symptomatic coronary artery disease is increased in diabetic patients. Many of us have also been taught that diabetic patients with myocardial infarction present with atypical symptoms of acute infarction and are frequently admitted to hospital with painless myocardial infarction. Another easily accepted notion is that autonomic damage is responsible for the increased frequency of painless ischemic episodes. However, all of these contentions are open to discussion. The purpose of this article is to make a critical review of the available information on these relationships.
SILENT MYOCARDIAL INFARCTION AND DIABETES -
Bradley and Schonfeld (1) demonstrated that diabetic patients hospitalized for myocardial infarction more often had little or no pain during infarction than did nondiabetic patients. This result does not definitely mean that painless or atypical myocardial infarction is abnormally common in the whole diabetic population, although it was more common in the proportion of patients who were hospitalized at the time of infarction. Selection bias may modify results, which are based on hospital records. It is possible that the diabetic patients had a closer medical follow-up, including closer electrocardiographic surveillance, or that they sought medical attention and were hospitalized more readily because of symptoms related to their diabetic status, e.g., uncontrolled diabetes, nausea, or general weakness. These circumstances could have erroneously increased the frequency of painless and atypical infarctions in the hospitalized diabetic patients compared with hospitalized nondiabetic patients. Population-based epidemiological studies are likely to give a more reliable picture of the incidence of unrecognized myocardial infarctions in diabetic populations, although the electrocardiographic crite- ria of infarction and the interval between the recordings may affect the incidence.
The first population-based assessment of the association between diabetes and silent myocardial infarction was the Framingham Study (2) . In the 18-yr follow-up, a higher proportion of myocardial infarctions were silent or unrecognized not only in diabetic but also in hypertensive subjects (2) . However the fact that these differences were not statistically significant has often been ignored. In the less-frequently-referred-to 30-yr follow-up, hypertension and female gender were associated with an excessive occurrence of unrecognized infarctions but not diabetes (3). In the Israeli study, the incidence of unrecognized infarctions was related to age, left ventricular hypertrophy, and high blood pressure but not to diabetes (4), whereas a prevalence survey in Malta showed that 1.8% of 656 nondiabetic patients with myocardial infarction and 2.8% of 283 diabetic patients had no chest pain (5) . Similarly, pain as a presenting symptom was no less common in diabetic patients enrolled in the Multicenter Postinfarction Program (6) . The Western Collaborative Group Study has often been thought to support the association between silent myocardial infarctions and diabetes mellitus (7), but this investigation compared patients with unrecognized myocardial infarctions with subjects with no clinical coronary artery disease. Naturally, a trend toward a preponderance of diabetic subjects in the former group was found. This relationship may nevertheless reflect only the effect of diabetes mellitus in promoting atherosclerosis. A similar relationship was found with respect to other common risk factors. In summary, the above observations suggest that even if diabetic subjects have silent myocardial infarctions more often than nondiabetic subjects, silent or unrecognized infarctions relative to all episodes do not seem to be significantly increased in diabetic compared with nondiabetic patients.
SILENT CORONARY ARTERY DISEASE AND DIABETESThe
current literature cannot give a direct answer to the question of whether the proportion of asymptomatic coronary artery disease compared with symptomatic disease is abnormally high in diabetic subjects. There are three ways, with their inherent limitations, to analyze this question. 1) Do epidemiological studies reveal any differences in the relative risks of angina pectoris (symptomatic disease) and electrocardiographic changes? 2) Is exercise-induced silent myocardial ischemia abnormally common in presumably healthy diabetic subjects? 3) Do diabetic patients with documented coronary artery disease have more often silent ischemia than nondiabetic patients?
In the Israel Ischemic Heart Disease Study, the incidence of new angina pectoris was 3.2 times higher in previously diagnosed diabetic than nondiabetic patients whereas that of myocardial infarction (electrocardiographic diagnosis) was only 1.5 times higher (8) . Similarly, in the diabetic subjects of the Framingham cohort, the relative risk of angina pectoris was comparable to the risk of other manifestations of coronary artery disease (9) . In a crosssectional study from California, resting electrocardiographic abnormalities suggestive of asymptomatic ischemic heart disease were associated with non-insulin-dependent diabetes mellitus (10) . On the other hand, there are at least three other large studies suggesting that the increase in the prevalence or incidence of symptomatic coronary artery disease is similar to that in ischemic electrocardiographic abnormalities in the diabetic population (11) (12) (13) . One limitation of epidemiological studies is that electrocardiographic diagnosis of coronary artery disease suffers from low sensitivity and specificity. Registration of subjective symptoms is also sensitive e.g., to verbal skills of the patient.
Exercise electrocardiography has been used to assess the prevalence of asymptomatic coronary artery disease in small series of presumably healthy diabetic subjects. The frequency of positive exercise electrocardiograms in asymptomatic middle-aged diabetic subjects has varied from 14 to 23% (14-16) compared with a prevalence of 6-12% (17) (18) (19) in asymptomatic nondiabetic subjects of similar age. Although exercise electrocardiogram is a more sensitive method than resting electrocardiogram, its reliability in totally asymptomatic subjects has been questioned because according to Bayes's theorem, the probability of false positive findings is high (20) . The lack of specificity is also a problem in thallium imaging. In two studies, 3 8 -5 2 % of patients with abnormal scans had no significant coronary artery disease (16, 21) . Therefore, it would be ideal if the positive findings of noninvasive tests could be ascertained with coronary arteriography. Wide application of invasive studies in asymptomatic subjects may result in ethical problems. Despite these limitations, the excess of asymptomatic disease seems to be quite comparable to the reported overall excess of coronary artery disease in diabetic populations.
Silent ischemia is common in patients with coronary artery disease, especially after myocardial infarction. There are several studies that have compared the clinical characteristics of patients with angiographically documented coronary artery disease who have either silent or painful myocardial ischemia (Table 1; [22] [23] [24] [25] [26] [27] [28] [29] . Although potential bias in the selection of patients for noninvasive testing cannot be excluded, these studies have not revealed any significant preponderance of diabetic subjects in the group with silent myocardial ischemia. In addition to these studies, there are two studies that DIABETES CARE, VOLUME 15, NUMBER 2, FEBRUARY 1992 have compared the prevalence of silent ischemia in diabetic and nondiabetic patients with probable coronary artery disease. Nesto et al. (30) studied 50 diabetic and 50 nondiabetic patients. Silent ischemia was more common in the diabetic group (72 vs. 32%, respectively). On the other hand, Callaham et al. (31) reported the results of 1747 patients, of whom 180 were diabetic and 317 had asymptomatic ischemia, and found that the prevalence of silent ischemia was similar in diabetic and nondiabetic patients (62 vs. 60%). Angiographic data was available only in 18% of the study patients and Nesto et al. did not include angiographic data. Taken together, all the above-mentioned results suggest indirectly that the increase in silent coronary artery disease is quite similar to that in painful and overall coronary artery disease in the diabetic population.
DIABETIC AUTONOMIC NEUROPATHY AND SILENT
MYOCARDIAL INFARCTION AND ISCHEMIA-The afferent fibers running through the cardiac sympathetic nerves form the essential pathway for the transmission of cardiac pain (32) . It is reasonable to assume that diabetic autonomic neuropathy may interfere with the afferent cardiac sensory impulses in view of the abnormalities encountered in efferent parasympathetic and sympathetic cardiac control. The idea that autonomic damage is responsible for the increased frequency of painless infarctions and ischemia in diabetes is based primarily on the small autopsy series of Faerman et al. (33) , who found various degrees of neuropathic change in the visceral pericardial nerve fibers of five diabetic patients with silent myocardial infarction but not in five patients with painful infarctions. Only three of the patients with painless myocardial infarction had clinical neuropathy. No data on the extent of myocardial damage or coronary atherosclerosis were available.
Niakan et al. (34) found that diabetic patients with an abnormal Valsalva ratio, which was suggested to reflect autonomic neuropathy, more often had a history of silent myocardial infarction than those with normal Valsalva ratio, i.e., normal autonomic nervous function. At first, this finding seems to support an association between autonomic damage and silent myocardial infarction. However, it must be remembered that autonomic neuropathy cannot be diagnosed on the basis of one abnormal cardiovascular reflex. Furthermore, myocardial infarction is associated with autonomic dysfunction (35) (36) (37) (38) , which may cause similar alterations in Valsalva ratio as diabetic autonomic neuropathy (35) . Therefore, in a critical interpretation the findings described by Niakan et al. may only reflect the often disregarded effect of myocardial infarction on autonomic nervous function. Note that the proportions of episodes of myocardial infarctions that were silent were comparable in the patients with abnormal and normal Valsalva ratios.
Interest has turned to the potential association between diabetic autonomic neuropathy and silent myocardial ischemia. Ambepityia et al. (39) studied diabetic and nondiabetic patients with angina pectoris (i.e., symptomatic disease) with exercise electrocardiography and found that the diabetic patients experienced chest pain later after the onset of ST depression than did nondiabetic patients. Those patients with the most prominent abnormality, i.e., six nondiabetic and eight diabetic patients who failed to develop chest pain during testing, despite diagnostic ST segment depressions, were, however, excluded from analysis and the data on the severity of coronary artery disease were incomplete. The delay in the perception of pain was related to the impairment of autonomic nervous function, i.e., heart rate variation during deep breathing and the Valsalva ratio. However, it was significant that a similar relationship was also noted in the nondiabetic group, who are unlikely to have autonomic neuropathy but rather autonomic dysfunction related to the severe coronary artery disease (35-38,40,41) .
Nesto et al. (30) assessed the reliability of angina pectoris as a sign of coronary artery disease in consecutive diabetic patients referred for exercise thallium scintigraphy. As previously discussed, they found that diabetic patients were more often asymptomatic than nondiabetic patients. However, the lack of symptoms was not related to the presence of neuropathy.
The findings of Nesto et al. (30) are in agreement with those of Hume et al. (15) , who demonstrated that an abnormal exercise electrocardiogram is no more common in asymptomatic diabetic patients with peripheral or autonomic neuropathy than in those without.
Koistinen et al. (16) recently screened a large population-based group of middle-aged diabetic subjects and found 14 patients with asymptomatic coronary artery disease and exercise-induced myocardial ischemia (42) . Their autonomic function was compared with that of a group of consecutive diabetic patients catheterized in the same institution because of severe chest pain. The groups did not differ in regard to the autonomic function tests. Detailed data were also obtained on the coronary anatomy of the patients, showing the asymptomatic diabetic patients to have a milder coronary artery disease compared with the symptomatic ones. Unfortunately, the above-mentioned investigations into silent ischemia in diabetic patients had no data on the coronary anatomy (15, 30, 39) .
The question of the potential association between diabetic autonomic neuropathy and silent myocardial infarction and ischemia is difficult to answer. Cardiac sympathetic afferent fibers constitute the main pathway for the transmission of cardiac pain (32) . One limitation on any clinical evaluation of the association of autonomic neuropathy with the lack of cardiac pain is that this part of autonomic function is difficult to assess. The heartrate responses used for the conventional diagnosis of autonomic neuropathy mainly reflect the integrity of cardiac parasympathetic activity, and an additional problem with the heart-rate tests is the confounding effect of coronary artery disease and myocardial infarction (35) (36) (37) (38) 40, 41) . Preliminary studies suggest that the distribution of myocardial sympathetic nerves may be assessed with radiolabeled metaiodobenzylguanidine (43) . The technique has not been used in the evaluation of silent myocardial ischemia or infarction.
It is not known how severe the autonomic neuropathy must be to interfere significantly with pain perception. This question is important, because if an advanced and infrequently encountered damage is required, its influence would be easily obscured in epidemiological studies. Note that even patients with advanced autonomic neuropathy may develop severe pain during acute myocardial infarction (44) .
The mechanisms of silent myocardial ischemia are complex and controversial even in nondiabetic patients. Less-severe ischemia, i.e., less myocardium at jeopardy, milder or shorter ischemic episodes, insufficient to meet the threshold of pain, localized alteration in the pain threshold due to destruction of the nociceptive pathways, e.g., by myocardial infarction, and variation in the general pain threshold may contribute to the differences between silent and painful myocardial ischemia (45) .
CONCLUSIONS-In summary, we believe that there is nothing mysterious in the silent coronary artery disease of diabetic patients. Diabetic subjects have accelerated coronary atherosclerosis; all clinical manifestations of coronary artery disease are abnormally common in diabetic subjects; it is quite natural also that the milder preclinical and asymptomatic forms of the disease are more common. Similarly, if we assessed asymptomatic middle-aged patients with familial hypercholesterolemia, we would not be surprised to find asymptomatic coronary artery disease to be common. No study shows that asymptomatic coronary artery disease or myocardial infarction is more severe (assessed by cardiac catheterization and degree of ischemia) in diabetic subjects compared with nondiabetic patients. The association of autonomic neuropathy to unrecognized myocardial infarctions or silent myocardial ischemia is still unsubstantiated, although the theoretical background of the association may capture the imagination of investigators and physicians.
